RHYTHM PHARMACEUTICALS, INC. (16)
Browse by Contract Category
Contracts
-
Asset Purchase Agreement, dated as of January 5, 2021, by and between Rhythm Pharmaceuticals, Inc. and Alexion Pharmaceuticals, Inc
(Filed With SEC on January 5, 2021)
-
Separation Agreement, dated September 30, 2020, between Rhythm Pharmaceuticals, Inc. and Nithya Desikan
(Filed With SEC on November 2, 2020)
-
Amendment No. 2 to Development and Manufacturing and Services Agreement, dated as of July 15, 2020, by and between the Company and Corden Pharma Brussels S.A
(Filed With SEC on August 3, 2020)
-
Offer Letter, dated July 16, 2020, between Rhythm Pharmaceuticals, Inc. and David P. Meeker, M.D
(Filed With SEC on July 21, 2020)
-
First Amendment to Lease, dated April 15, 2016
(Filed With SEC on March 8, 2019)
-
Offer Letter, dated September 4, 2020, and Indefinite Term Employment Contract, dated October 5, 2020, between Rhythm Pharmaceuticals, Inc. and Yann Mazabraud
(Filed With SEC on November 2, 2020)
-
Summary of Non-Employee Director Compensation Policy
(Filed With SEC on May 4, 2020)
-
Offer Letter, dated December 21, 2017, by and between the Company and Hunter C. Smith
(Filed With SEC on May 4, 2020)
-
Amendment No. 1 to Development and Manufacturing and Services Agreement, dated as of February 20, 2020, by and between the Company and Corden Pharma Brussels S.A
(Filed With SEC on May 4, 2020)
-
Description of the Registrants Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 2, 2020)
-
Form of Restricted Stock Unit Award Agreement
(Filed With SEC on March 2, 2020)
-
Separation Agreement and General Release dated January 6, 2020
(Filed With SEC on January 8, 2020)
-
Consulting Agreement dated January 6, 2020
(Filed With SEC on January 8, 2020)
-
Underwriting Agreement dated October 15, 2019
(Filed With SEC on October 16, 2019)
-
Summary of Non-Employee Director Compensation Policy
(Filed With SEC on July 25, 2019)
-
Offer Letter, dated September 13, 2017, by and between the Registrant and Lex H.T. Van der Ploeg
(Filed With SEC on March 8, 2019)